AAAAAA

   
Results: 1-14 |
Results: 14
Treatment with BAT monoclonal antibody decreases tumor burden in a murine model of leukemia/lymphoma
Authors: Hardy, B Indjiia, L Rodionov, G Raiter, A Inbal, A
Citation: B. Hardy et al., Treatment with BAT monoclonal antibody decreases tumor burden in a murine model of leukemia/lymphoma, INT J ONCOL, 19(5), 2001, pp. 897-902
Genetic evidence for the transcriptional-activating function of Homothoraxduring adult fly development
Authors: Inbal, A Halachmi, N Dibner, C Frank, D Salzberg, A
Citation: A. Inbal et al., Genetic evidence for the transcriptional-activating function of Homothoraxduring adult fly development, DEVELOPMENT, 128(18), 2001, pp. 3405-3413
Pharmacokinetic studies with FVIII/von Willebrand factor concentrate can be a diagnostic tool to distinguish between subgroups of patients with acquired von Willebrand syndrome
Authors: Luboshitz, J Lubetsky, A Schliamser, L Kotler, A Tamarin, I Inbal, A
Citation: J. Luboshitz et al., Pharmacokinetic studies with FVIII/von Willebrand factor concentrate can be a diagnostic tool to distinguish between subgroups of patients with acquired von Willebrand syndrome, THROMB HAEM, 85(5), 2001, pp. 806-809
Cerebrovascular events in patients with significant stenosis of the carotid artery are associated with hyperhomocysteinemia and platelet antigen-1 (Leu33Pro) polymorphism
Authors: Streifler, JY Rosenberg, N Chetrit, A Eskaraev, R Sela, BA Dardik, R Zivelin, A Ravid, B Davidson, J Seligsohn, U Inbal, A
Citation: Jy. Streifler et al., Cerebrovascular events in patients with significant stenosis of the carotid artery are associated with hyperhomocysteinemia and platelet antigen-1 (Leu33Pro) polymorphism, STROKE, 32(12), 2001, pp. 2753-2758
S-nitrosoderivative of a recombinant fragment of von Willebrand factor (S-nitroso-AR545C) inhibits thrombus formation in guinea pig carotid artery thrombosis model
Authors: Gurevitz, O Eldar, M Skutelsky, E Tamarin, I Shenkman, B Eskaraev, R Castel, D Loscalzo, J Inbal, A
Citation: O. Gurevitz et al., S-nitrosoderivative of a recombinant fragment of von Willebrand factor (S-nitroso-AR545C) inhibits thrombus formation in guinea pig carotid artery thrombosis model, THROMB HAEM, 84(5), 2000, pp. 912-917
Factor V leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children
Authors: Kenet, G Sadetzki, S Murad, H Martinowitz, U Rosenberg, N Gitel, S Rechavi, G Inbal, A
Citation: G. Kenet et al., Factor V leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children, STROKE, 31(6), 2000, pp. 1283-1288
Recombinant fragment of von Willebrand factor AR545C inhibits platelet binding to thrombin and platelet adhesion to thrombin-treated endothelial cells
Authors: Dardik, R Varon, D Eskaraev, R Tamarin, T Inbal, A
Citation: R. Dardik et al., Recombinant fragment of von Willebrand factor AR545C inhibits platelet binding to thrombin and platelet adhesion to thrombin-treated endothelial cells, BR J HAEM, 109(3), 2000, pp. 512-518
S-nitrosoderivative of a recombinant fragment of von Willebrand factor (S-nitroso-Ar545c): A unique antithrombotic agent
Authors: Inbal, A
Citation: A. Inbal, S-nitrosoderivative of a recombinant fragment of von Willebrand factor (S-nitroso-Ar545c): A unique antithrombotic agent, ISR MED ASS, 1(4), 1999, pp. 290-291
Plasma glutathione peroxidase deficiency and platelet insensitivity to nitric oxide in children with familial stroke
Authors: Kenet, G Freedman, J Shenkman, B Regina, E Brok-Simoni, F Holzman, F Vavva, F Brand, N Michelson, A Trolliet, M Loscalzo, J Inbal, A
Citation: G. Kenet et al., Plasma glutathione peroxidase deficiency and platelet insensitivity to nitric oxide in children with familial stroke, ART THROM V, 19(8), 1999, pp. 2017-2023
Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism - Prevalence and risk assessment
Authors: Salomon, O Steinberg, DM Zivelin, A Gitel, S Dardik, R Rosenberg, N Berliner, S Inbal, A Many, A Lubetsky, A Varon, D Martinowitz, U Seligsohn, U
Citation: O. Salomon et al., Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism - Prevalence and risk assessment, ART THROM V, 19(3), 1999, pp. 511-518
Safety and efficacy of continuous infusion of a combined factor VIII - vonWillebrand factor (vWF) concentrate (Haemate-P (TM)) in patients with von Willebrand disease
Authors: Lubetsky, A Schulman, S Varon, D Martinowitz, U Kenet, G Gitel, S Inbal, A
Citation: A. Lubetsky et al., Safety and efficacy of continuous infusion of a combined factor VIII - vonWillebrand factor (vWF) concentrate (Haemate-P (TM)) in patients with von Willebrand disease, THROMB HAEM, 81(2), 1999, pp. 229-233
Unique antiplatelet effects of a novel S-nitrosoderivative of a recombinant fragment of von Willebrand factor, AR545C: In vitro and ex vivo inhibition of platelet function
Authors: Inbal, A Gurevitz, O Tamarin, I Eskaraev, R Chetrit, A Novicov, I Feldman, M Varon, D Eldar, M Loscalzo, J
Citation: A. Inbal et al., Unique antiplatelet effects of a novel S-nitrosoderivative of a recombinant fragment of von Willebrand factor, AR545C: In vitro and ex vivo inhibition of platelet function, BLOOD, 94(5), 1999, pp. 1693-1700
Extensive venous and arterial thrombosis associated with an inhibitor to activated protein C
Authors: Zivelin, A Gitel, S Griffin, JH Xu, X Fernandez, JA Martinowitz, U Cohen, Y Halkin, H Seligsohn, U Inbal, A
Citation: A. Zivelin et al., Extensive venous and arterial thrombosis associated with an inhibitor to activated protein C, BLOOD, 94(3), 1999, pp. 895-901
Synergistic effects of prothrombotic polymorphisms and atherogenic factorson the risk of myocardial infarction in young males
Authors: Inbal, A Freimark, D Modan, B Chetrit, A Matetzky, S Rosenberg, N Dardik, R Baron, Z Seligsohn, U
Citation: A. Inbal et al., Synergistic effects of prothrombotic polymorphisms and atherogenic factorson the risk of myocardial infarction in young males, BLOOD, 93(7), 1999, pp. 2186-2190
Risultati: 1-14 |